Solugen, Inc.

Founded in 2016 and based in Texas, US, Solugen, Inc. is a developer of a clean technology that helps in the conversion of plant sugars into hydrogen peroxide by using gene editing and oxidase enzymes for industrial applications. The company was co-founded by Gaurab Chakrabarti (CEO) and Sean Hunt. In March 2026, Solugen, Inc.

raised USD 50 million in growth capital funding led by Idealist Capital, with participation from Public Sector Pension Investment Board. The company offers a carbon-negative molecular manufacturing platform called the BioForge. The solution scales synthetic biology without the use of fermentation or costly immobilization in order to convert inexpensive feedstock directly into valuable product molecules while avoiding the formation of waste products. It converts plant sugars into hydrogen peroxide by using gene editing and oxidase enzymes for various industrial applications such as semiconductor and electronics fabrication, water purification, aseptic packaging, precious metal mining, food and feed production, textiles and pulp bleaching, biocide disinfectants, plastics production, various chemical syntheses, and rocket propulsion.

The company also offers BioSol and ScavSol solutions, a technology that helps in cleaning and oxidizing water using oil and gas, wastewater treatment, and mining chemicals. Solugen generates revenue by producing and selling bio-based chemicals through its proprietary Bioforge™ platform, which converts plant-derived feedstocks into sustainable alternatives to fossil fuel-based products. The company will use the March 2026 funding to expand capacity at its existing plant in Quebec, construct a second facility, and support growing demand across North America's organic farming market.